Jennifer Tremmel

Clinical Focus

• Cardiology (Heart)
• Cardiovascular Disease
• Women's Heart Health
• Women's Cardiovascular Disease

Administrative Appointments

• Clinical Director, Women's Heart Health at Stanford (2007 - present)
• Director, Secondary Prevention Program (2006 - present)

Professional Education

Internet Links

• Women's Heart Health at Stanford

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information

Current Research Interests

Dr. Tremmel studies sex differences in cardiovascular disease. She is currently investigating sex differences in coronary endothelial function, plaque deposition, and the microcirculation of women and men who present with chest pain, but have normal appearing coronary arteries by angiography. She is also leading Stanford�s participation in the multi-center VIRGO trial, which is evaluating sex differences in young patients who present with myocardial infarction. Other active research projects include sex differences in chronic total coronary occlusions, the impact of stress on anginal symptoms, and vascular access site complications. Dr. Tremmel keeps Stanford�s Tako-tsubo Patient Registry and is conducting a multi-center study to investigate the relationship of stress and coping to genetic polymorphisms in patients with Tako-tsubo.

Clinical Trials

• Sex Differences in Coronary Pathophysiology Recruiting
• A Prospective, Single Blind, Randomized Controlled Study to Evaluate the Safety and Effectiveness of the Tryton Side Branch Stent� used in Conjunction with a Drug-Eluting Stent Compared to Side Branch Balloon Angioplasty in Conjunction with a Drug-Eluting Stent in the Treatment of de novo Bifurcation Lesions Involving the Main Branch and Side Branch within the Native Coronary Circulation Recruiting
• Fractional Flow Reserve-Guided Percutaneous Coronary Intervention plus Optimal Medical Treatment versus Optimal Medical Treatment Alone in Patients with Stable Coronary Artery Disease Recruiting
• The use of the TAXUS Libert� stent in conjunction with a medication called prasugrel (Effient). Recruiting

Publications

• Comparison of drug-eluting versus bare metal stents in cardiac allograft vasculopathy. Tremmel JA, Ng MK, Ikeno F, Hunt SA, Lee DP, Yeung AC, Fearon WF. Am J Cardiol. 2011; 108 (5): 665-8
• Images in intervention. Intramural hematoma appearing as a new lesion after coronary stenting. Tremmel JA, Koizumi T, O'Loughlin A, Yeung AC. JACC Cardiovasc Interv. 2011; 4 (1): 129-30
• Sex Differences in Neointimal Hyperplasia Following Endeavor Zotarolimus-Eluting Stent Implantation. Nakatani D, Ako J, Tremmel JA, Waseda K, Otake H, Koo BK, Miyazawa A, Hongo Y, Hur SH, Sakurai R, Yock PG, Honda Y, Fitzgerald PJ. Am J Cardiol. 2011
• Launching a successful transradial program. Tremmel JA, J Invasive Cardiol. 2009; 21 (8 Suppl A): 3A-10A
• Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction. Fearon WF, Shah M, Ng M, Brinton T, Wilson A, Tremmel JA, Schnittger I, Lee DP, Vagelos RH, Fitzgerald PJ, Yock PG, Yeung AC. J Am Coll Cardiol. 2008; 51 (5): 560-5